Gyre Therapeutics Inc. (GYRE)
NASDAQ: GYRE
· Real-Time Price · USD
8.74
-0.13 (-1.47%)
At close: Oct 16, 2025, 3:59 PM
8.74
0.00%
After-hours: Oct 16, 2025, 04:10 PM EDT
-1.47% (1D)
| Bid | 8.41 |
| Market Cap | 793.24M |
| Revenue (ttm) | 102.19M |
| Net Income (ttm) | 8.04M |
| EPS (ttm) | 0.02 |
| PE Ratio (ttm) | 437 |
| Forward PE | 53.4 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 9.29 |
| Volume | 126,984 |
| Avg. Volume (20D) | 93,478 |
| Open | 9.00 |
| Previous Close | 8.87 |
| Day's Range | 8.70 - 9.42 |
| 52-Week Range | 6.11 - 19.00 |
| Beta | 2.20 |
| Ex-Dividend Date | n/a |
About GYRE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GYRE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GYRE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsGyre Therapeutics Inc. is scheduled to release its earnings on
Nov 12, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 day ago
+10.74%
Gyre Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
6 days ago
+11.33%
Gyre Therapeutics shares are trading higher after Jefferies initiated coverage on the stock with a Buy rating and announced a $16 price target.